BackAMAG Pharmaceuticals Overview

AMAG Pharmaceuticals Current Cash

AMAG Pharmaceuticals's current cash is $170M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$168.90M
↓ 11.82% YoYΔ $-22.64M vs prior year quarter

Peer trimmed avg / median

Loading

AMAG Pharmaceuticals Current Cash History

Loading

AMAG Pharmaceuticals vs. peers: Current Cash Comparison

Loading

AMAG Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

AMAG Pharmaceuticals (AMAG) FAQ

As of the most recent data (September 2020), AMAG shows a current cash of $170M. That compares with $190M in the prior-year period — down 11.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AMAG's current cash is now $170M (was $190M) — a 11.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether AMAG Pharmaceuticals is outperforming or lagging.

Tracking AMAG's current cash over time shows whether AMAG Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $170M That compares with $190M in the prior-year period — down 11.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has AMAG Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $170M) with ownership activity and broader fundamentals.

AMAG Pharmaceuticals's current cash is $170M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.